Carboplatin-Ebeve: an alkylating agent for the treatment of cancer
Carboplatin-Ebeve is a pharmaceutical drug belonging to the group of alkylating agents and platinum derivatives. It is used to treat a variety of cancers, including ovarian cancer, testicular cancer, small cell lung cancer, squamous cell cancer of the head and neck, cervical and uterine cancer, breast cancer, and soft tissue sarcoma.
The manufacturer of Carboplatin-Ebewe is Ebewe Pharma GmbH, located in Austria. The drug is presented in the form of a concentrate for the preparation of an infusion solution in three different dosages: 50 mg, 150 mg and 450 mg. The active substance contained in the drug is Carboplatin.
When using Carboplatin-Ebeve, some contraindications must be taken into account. The drug is not recommended for hypersensitivity to platinum or other platinum-containing drugs, severe renal impairment, myelosuppression, pregnancy, lactation, or clinical signs of bleeding.
Like any medicine, Carboplatin-Ebeve may cause side effects. Some of them include myelosuppression (decrease in the number of platelets, white blood cells and red blood cells), gastrointestinal disorders (nausea, vomiting, diarrhea, changes in taste), decreased hearing acuity, paresthesia, liver dysfunction, alopecia, increased creatinine and urea levels, hypomagnesemia, hypokalemia, hypocalcemia, fever, chills and allergic reactions.
It is important to note that Carboplatin-Ebeve may interact with some other medications. For example, it is pharmaceutically incompatible with aluminum salts and may enhance the nephrotoxicity of propranolol, aminoglycosides and diazoxide.
Before starting treatment with Carboplatin-Ebeve, it is important to conduct a medical consultation and notify the doctor about all concomitant diseases and medications taken. During the course of treatment, it is necessary to regularly monitor blood composition and liver and kidney function.
Although the information on Carboplatin-Ebeve was presented based on a 2003 source (Drug Encyclopedia), I would like to point out that my knowledge base is only updated to September 2021 and I do not have access to the latest drug information . We recommend that you consult trusted and current sources, such as official medical resources or directly with your doctor or pharmacist, for information about Carboplatin-Ebeve or any other drug that you are interested in.